2018/03
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).Clin Microbiol Infect. 2018 Feb 15. pii: S1198-743X(18)30182-4 [Epub ahead of print]. F.I.: 5.292
Autores/as:
Reinwald M, Silva JT, Mueller NJ, Fortún J, Garzoni C, de Fijter JW, Fernández-Ruiz M, Grossi P, Aguado JM
Servicio:
Enfermedades Infecciosas. Complejo Hospitalario Universitario de Badajoz
Tipo:
Artículo
Materia: